Home › Compare › SIELF vs JNJ

SIELF vs JNJ: Dividend Comparison 2026

SIELF yields 329.08% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SIELF wins by $18528076456225804.00M in total portfolio value
10 years
SIELF
SIELF
● Live price
329.08%
Share price
$0.61
Annual div
$2.00
5Y div CAGR
81.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18528076456225804.00M
Annual income
$18,499,570,992,390,452,000,000.00
Full SIELF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — SIELF vs JNJ

📍 SIELF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSIELFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SIELF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SIELF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SIELF
Annual income on $10K today (after 15% tax)
$27,972.03/yr
After 10yr DRIP, annual income (after tax)
$15,724,635,343,531,884,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, SIELF beats the other by $15,724,635,343,531,884,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SIELF + JNJ for your $10,000?

SIELF: 50%JNJ: 50%
100% JNJ50/50100% SIELF
Portfolio after 10yr
$9264038228112902.00M
Annual income
$9,249,785,496,195,226,000,000.00/yr
Blended yield
99.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SIELF
No analyst data
Altman Z
0.7
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SIELF buys
0
JNJ buys
0
No recent congressional trades found for SIELF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSIELFJNJ
Forward yield329.08% ✓2.14%
Annual dividend / share$2.00$5.20 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR81.5% ✓28%
Portfolio after 10y$18528076456225804.00M ✓$30.5K
Annual income after 10y$18,499,570,992,390,452,000,000.00 ✓$4,749.88
Total dividends collected$18526207050487964.00M ✓$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SIELF vs JNJ ($10,000, DRIP)

YearSIELF PortfolioSIELF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$70,429$59,728.51$10,594$274.49+$59.8K → SIELF
2$788,906$713,547.67$11,294$360.69+$777.6K → SIELF
3$14,402,039$13,557,908.94$12,133$476.91+$14.39M → SIELF
4$435,250,537$419,840,355.62$13,156$635.42+$435.24M → SIELF
5$21,988,201,385$21,522,483,311.04$14,432$854.61+$21988.19M → SIELF
6$1,867,844,598,422$1,844,317,222,939.43$16,056$1,162.76+$1867844.58M → SIELF
7$267,752,409,179,362$265,753,815,459,050.56$18,175$1,604.53+$267752409.16M → SIELF
8$64,906,205,357,370,980$64,619,710,279,549,064.00$21,009$2,252.68+$64906205357.35M → SIELF
9$26,640,620,406,874,665,000$26,571,170,767,142,280,000.00$24,911$3,229.73+$26640620406874.64M → SIELF
10$18,528,076,456,225,805,000,000$18,499,570,992,390,452,000,000.00$30,458$4,749.88+$18528076456225804.00M → SIELF

SIELF vs JNJ: Complete Analysis 2026

SIELF — Stock

Shanghai Electric Group Company Limited, an equipment manufacturing conglomerate, provides clean energy, new energy and environmental protection, and industrial equipment, and modern services in the People's Republic of China. It offers coal-fired power generation and corollary, gas-fired power generation, wind power, nuclear power, and energy storage equipment, as well as vessels for chemical industry. The company also provides elevators, electric motors and ramps, and industrial basic parts; intelligent manufacturing, and construction industrialization equipment; and power grid and industrial intelligent power supply system solutions. In addition, it offers energy, and environmental protection and automation engineering; industrial internet; financing leases and insurance brokerage; international trade; and property services. Shanghai Electric Group Company Limited was incorporated in 2004 and is based in Shanghai, the People's Republic of China. Shanghai Electric Group Company Limited is a subsidiary of Shanghai Electric (Group) Corporation.

Full SIELF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SIELF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SIELF vs SCHDSIELF vs JEPISIELF vs OSIELF vs KOSIELF vs MAINSIELF vs ABBVSIELF vs MRKSIELF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.